
CellMosaic LLC Profile last edited on: 9/11/2013
CAGE: 5ENZ5
UEI: HXTQC38ME745
Business Identifier: Bioconjugation reagents and platform technologies for drug development, biodetection, and basic research Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Worcester
Congr. District: 02
County: Worcester
Public Profile
CellMosaic is a private biotech company focusing on the development of bioconjugation reagents and platform technologies for drug development, biodetection, and basic research. CellMosaic has been developing new crosslinking chemistries, a small molecule and biologic drug conjugation/delivery platform, and single or site-specific labeling methods for biopolymers. They recently filed a patent application for new crosslinking reagents and developed our proprietary AqueaTether (AqT) technology platform for drug bioconjugation and delivery. Additionally, they offer bioconjugate drug development through either the classical approach or their proprietary AqT technologies. CellMosaic can also facilitates biological research by offering a wide range of crosslinking reagents, ready-to-go kits, bioconjugates, and custom bioconjugation.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2012 | 1 | NIH | $159,691 | |
Project Title: Contact Site Mapping Of Transient Protein-Protein Complexes At The Molecular Leve |
Key People / Management
Yumei Huang -- Founder, President & CEO, Inventor of AqT� Technologies
Shuyan Chen -- Director of Biology
Shuyan Chen -- Director of Biology